Nicole S. Jones - Feb 28, 2025 Form 4 Insider Report for Cigna Group (CI)

Role: EVP, Chief Administrative Officer and General Counsel Exhibit List: EX-24 Power of Attorney poajones.txt
Signature: Matthew Arnold, attorney-in-fact
Stock symbol: CI
Transactions as of: Feb 28, 2025
Transactions value $: -$3,073,659
Form type: 4
Date filed: 3/4/2025, 07:52 PM
Previous filing: Aug 14, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CI	Common Stock, $.01 Par Value	Award	$0	+9.06K	+33.3%	$0.00	36.3K	Feb 28, 2025	Direct	F1
transaction	CI	Common Stock, $.01 Par Value	Award	$0	+3.15K	+8.67%	$0.00	39.4K	Feb 28, 2025	Direct	F2
transaction	CI	Common Stock, $.01 Par Value	Tax liability	-$290K	-949	-2.41%	$305.86	38.5K	Feb 28, 2025	Direct	F3
transaction	CI	Common Stock, $.01 Par Value	Tax liability	-$1.27M	-4.16K	-10.81%	$305.86	34.3K	Feb 28, 2025	Direct	F4
transaction	CI	Common Stock, $.01 Par Value	Sale	-$1.51M	-4.9K	-14.29%	$308.12	29.4K	Mar 3, 2025	Direct	F5
holding	CI	Common Stock, $.01 Par Value						1.41K	Feb 28, 2025	By 401(k)	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CI	Employee Stock Option (Right to Buy)	Award	$0	+11.2K		$0.00	11.2K	Feb 28, 2025	Common Stock, $.01 Par Value	11.2K	$305.86	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2	These restricted shares vest in three equal annual installments beginning March 1, 2026.
F3	Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F4	Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F5	This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.
F6	Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F7	This option vests in three equal annual installments beginning March 1, 2026.

Remarks:

EVP, Chief Administrative Officer and General Counsel Exhibit List: EX-24 Power of Attorney poajones.txt